Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Hybrid materials made of cardiac cells and carbon nanotubes might patch damaged hearts and provide muscle for robots made of living tissues.
ExxonMobil invests $300 million in Synthetic Genomics to develop algae biofuel.
Amyris’s large-scale demonstration plant will make diesel from sugarcane.
Two steps forward and one step back for stem cells, genome sequencing to diagnose disease, and the creation of artificial life.
A new type of genetic switch gives bioengineers better control over microbes.
Newly engineered E. coli streamline the conversion of cellulose into fuel.
A simpler way to modify microbes could help produce biofuels and drugs efficiently.
A genome built from scratch is a step toward synthesizing novel organisms.
Thanks to extensive genetic engineering, drugmakers can now brew large vats of the malaria drug artemisinin, stabilizing the world supply.